NDC Code 13733-290-01 | pharmacompass.com

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

MISSHA The Original Tension Pact Intense Moisture SPF37 No13Titanium Dioxide, Octinoxate, Zinc Oxide, CREAM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE(UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 mg in 1 g
TITANIUM DIOXIDE(UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	9.69 mg in 1 g
ZINC OXIDE(UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	2.94 mg in 1 g

Ingredient Name	Strength
Inactive Ingredients
PENTYLENE GLYCOL(UNII: 50C1307PZG)
DISTEARDIMONIUM HECTORITE(UNII: X687XDK09L)
PEG-10 DIMETHICONE (600 CST)(UNII: 8PR7V1SVM0)
TRIS(TRIMETHYLSILOXY)PHENYLSILANE(UNII: S3QI0ZXT5X)
WATER(UNII: 059QF0KO0R)
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)(UNII: V2W71V8T0X)
NIACINAMIDE(UNII: 25X51I8RD4)
DEXTRIN PALMITATE (CORN; 20000 MW)(UNII: 89B2BSF9I3)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
CYCLOMETHICONE 6(UNII: XHK3U310BA)
CYCLOMETHICONE 5(UNII: 0THT5PCI0R)
GLYCERIN(UNII: PDC6A3C0OX)
BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE(UNII: 75D21FL1PI)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13733-290-01	14 g in 1 CARTON Type 0: Not a Combination Product	02/01/2017

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part352	02/01/2017

MISSHA The Original Tension Pact Intense Moisture SPF37 No21Titanium Dioxide, Octinoxate, Zinc Oxide, CREAM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE(UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 mg in 1 g
TITANIUM DIOXIDE(UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	9.69 mg in 1 g
ZINC OXIDE(UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	2.94 mg in 1 g

Ingredient Name	Strength
Inactive Ingredients
PENTYLENE GLYCOL(UNII: 50C1307PZG)
DISTEARDIMONIUM HECTORITE(UNII: X687XDK09L)
PEG-10 DIMETHICONE (600 CST)(UNII: 8PR7V1SVM0)
TRIS(TRIMETHYLSILOXY)PHENYLSILANE(UNII: S3QI0ZXT5X)
WATER(UNII: 059QF0KO0R)
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)(UNII: V2W71V8T0X)
NIACINAMIDE(UNII: 25X51I8RD4)
DEXTRIN PALMITATE (CORN; 20000 MW)(UNII: 89B2BSF9I3)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
CYCLOMETHICONE 6(UNII: XHK3U310BA)
CYCLOMETHICONE 5(UNII: 0THT5PCI0R)
GLYCERIN(UNII: PDC6A3C0OX)
BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE(UNII: 75D21FL1PI)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13733-291-01	14 g in 1 CARTON Type 0: Not a Combination Product	02/01/2017

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part352	02/01/2017

MISSHA The Original Tension Pact Intense Moisture SPF37 No23Titanium Dioxide, Octinoxate, Zinc Oxide, CREAM

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OCTINOXATE(UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51)	OCTINOXATE	5 mg in 1 g
TITANIUM DIOXIDE(UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP)	TITANIUM DIOXIDE	9.69 mg in 1 g
ZINC OXIDE(UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	2.94 mg in 1 g

Ingredient Name	Strength
Inactive Ingredients
PENTYLENE GLYCOL(UNII: 50C1307PZG)
DISTEARDIMONIUM HECTORITE(UNII: X687XDK09L)
PEG-10 DIMETHICONE (600 CST)(UNII: 8PR7V1SVM0)
TRIS(TRIMETHYLSILOXY)PHENYLSILANE(UNII: S3QI0ZXT5X)
WATER(UNII: 059QF0KO0R)
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)(UNII: V2W71V8T0X)
NIACINAMIDE(UNII: 25X51I8RD4)
DEXTRIN PALMITATE (CORN; 20000 MW)(UNII: 89B2BSF9I3)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
CYCLOMETHICONE 6(UNII: XHK3U310BA)
CYCLOMETHICONE 5(UNII: 0THT5PCI0R)
GLYCERIN(UNII: PDC6A3C0OX)
BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE(UNII: 75D21FL1PI)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:13733-292-01	14 g in 1 CARTON Type 0: Not a Combination Product	02/01/2017

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part352	02/01/2017

NDC 13733-290-01
API & Excipient Details